| |
| |
|
| Insider
Information: |
Wilson Troy Edward |
| Relationship: |
Director |
| City: |
Los Angeles |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
93,642 |
|
|
Indirect Shares
|
974,552 |
|
|
| Direct
Value |
$1,772,040 |
|
|
|
Indirect Value
|
$22,246,969 |
|
|
| Total
Shares |
1,068,194 |
|
|
| Total
Value |
$24,019,009 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -67.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Puma Biotechnology Inc |
PBYI |
Director |
2023-06-13 |
27,350 |
2023-06-13 |
550 |
Premium* |
|
|
Kura Oncology Inc |
KURA |
|
2024-01-24 |
559 |
2024-01-24 |
579,194 |
Premium* |
|
|
Zosano Pharma Corp |
ZSAN |
Director |
2015-04-01 |
3,000 |
2015-04-01 |
0 |
Premium* |
|
|
Avidity Biosciences, Inc. |
RNA |
Director |
2023-12-12 |
62,733 |
2023-12-12 |
394,808 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2013-10-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
350 |
|
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2013-10-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
550 |
|
- |
|
| ZSAN |
Zosano Pharma Corp |
Director |
– • – |
2015-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2018-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,822 |
6,172 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2019-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
19,423 |
25,595 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2020-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
25,748 |
51,343 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2020-06-11 |
4 |
S |
$9.97 |
$251,693 |
D/D |
(25,245) |
26,098 |
0 |
% |
|
| RNA |
Avidity Biosciences, Inc. |
Director |
– • – |
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
189,618 |
|
- |
|
| RNA |
Avidity Biosciences, Inc. |
Director |
– • – |
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
711,067 |
|
- |
|
| RNA |
Avidity Biosciences, Inc. |
Director |
– • – |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
189,042 |
805,301 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Director |
– • – |
2020-12-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(100,000) |
89,618 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Director |
– • – |
2020-12-22 |
4 |
A |
$0.00 |
$0 |
I/I |
100,000 |
100,000 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2021-06-10 |
4 |
S |
$11.36 |
$292,433 |
D/D |
(25,748) |
350 |
0 |
% |
|
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
27,858 |
28,208 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
• • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
27,000 |
55,208 |
0 |
- |
|
| PBYI |
Puma Biotechnology Inc |
Director |
• • – |
2022-06-16 |
4 |
AS |
$2.58 |
$71,971 |
D/D |
(27,858) |
27,350 |
0 |
% |
|
| PBYI |
Puma Biotechnology Inc |
Director |
• • – |
2023-06-13 |
4 |
AS |
$3.45 |
$93,269 |
D/D |
(27,000) |
350 |
0 |
% |
|
| PBYI |
Puma Biotechnology Inc |
Director |
• • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
27,000 |
27,350 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Director |
– • – |
2023-12-12 |
4 |
A |
$0.00 |
$0 |
I/I |
550,000 |
300,000 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Director |
– • – |
2023-12-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(550,000) |
13,711 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2016-12-05 |
5 |
GD |
$0.00 |
$0 |
I/I |
1,000 |
1,735,991 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • • |
2017-04-21 |
4 |
OE |
$4.80 |
$24,000 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2017-08-22 |
4 |
OE |
$4.80 |
$134,328 |
D/D |
27,985 |
32,985 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2018-11-06 |
4 |
OE |
$4.80 |
$124,997 |
D/D |
26,041 |
59,026 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2020-02-11 |
4 |
OE |
$4.80 |
$136,461 |
D/D |
28,096 |
54,137 |
0 |
- |
|
65 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
